Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PULM similar filings
- 9 Nov 23 Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update
- 10 Aug 23 Pulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update
- 13 Jul 23 Submission of Matters to a Vote of Security Holders
- 11 Jul 23 Pulmatrix Announces Submission of IND Application to FDA to Initiate a Phase 2 Trial of Investigational Drug PUR3100 to Treat Acute Migraine
- 12 May 23 Pulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update
- 30 Mar 23 Pulmatrix Announces Year-End and Q4 Financial 2022 Results and Provides Corporate Update
- 6 Feb 23 Regulation FD Disclosure
Filing view
External links
Exhibit 99.2